Carbapenemase-producing Enterobacteriaceae in Europe: assessment by national experts from 38 countries, May 2015.
about
Epidemiology of Carbapenem Resistant Klebsiella pneumoniae Infections in Mediterranean CountriesSurveillance and Control of Antibiotic Resistance in the Mediterranean RegionEpidemiology and biomolecular characterization of carbapenem-resistant klebsiella pneumoniae in an Italian hospitalThe intensive care medicine research agenda on multidrug-resistant bacteria, antibiotics, and stewardship.Indistinguishable NDM-producing Escherichia coli isolated from recreational waters, sewage, and a clinical specimen in Ireland, 2016 to 2017.Increasing proportion of carbapenemase-producing Enterobacteriaceae and emergence of a MCR-1 producer through a multicentric study among hospital-based and private laboratories in Belgium from September to November 2015.Clinical and laboratory considerations for the rapid detection of carbapenem-resistant Enterobacteriaceae.Enhanced antimicrobial de-escalation for pneumonia in mechanically ventilated patients: a cross-over studyPhylogeny, resistome and mobile genetic elements of emergent OXA-48 and OXA-245 Klebsiella pneumoniae clones circulating in SpainBloodstream infections in neutropenic cancer patients: A practical update.Multisite Evaluation of Cepheid Xpert Carba-R Assay for Detection of Carbapenemase-Producing Organisms in Rectal Swabs.KPC-3-Producing Klebsiella pneumoniae in Portugal Linked to Previously Circulating Non-CG258 Lineages and Uncommon Genetic Platforms (Tn4401d-IncFIA and Tn4401d-IncN).Identification of Klebsiella pneumoniae Carbapenemase-producing Klebsiella oxytoca in Clinical Isolates in Tehran Hospitals, Iran by Chromogenic Medium and Molecular Methods.Antimicrobial resistance temporal trend of Klebsiella pneumoniae isolated from blood.Pathogens and antimicrobial susceptibility profiles in critically ill patients with bloodstream infections: a descriptive study.Assessment of the Activity of Tigecycline against Gram-Positive and Gram-Negative Organisms Collected from Italy between 2012 and 2014, as Part of the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.).Clinical efficacy of β-lactam/β-lactamase inhibitor combinations for the treatment of bloodstream infection due to extended-spectrum β-lactamase-producing Enterobacteriaceae in haematological patients with neutropaenia: a study protocol for a retrosMolecular Characterization of OXA-48-Like-Producing Enterobacteriaceae in the Czech Republic and Evidence for Horizontal Transfer of pOXA-48-Like Plasmids.Trends in carbapenemase-producing Enterobacteriaceae, France, 2012 to 2014.Genomic epidemiology of global VIM-producing Enterobacteriaceae.Global Molecular Epidemiology of IMP-Producing EnterobacteriaceaeCharacterization of carbapenemase-producing Enterobacteriaceae in the West Midlands region of England: 2007-14.The spread of KPC-producing Enterobacteriaceae in Spain: WGS analysis of the emerging high-risk clones of Klebsiella pneumoniae ST11/KPC-2, ST101/KPC-2 and ST512/KPC-3.Active surveillance scheme in three Romanian hospitals reveals a high prevalence and variety of carbapenamase-producing Gram-negative bacteria: a pilot study, December 2014 to May 2015.Detection and epidemiology of carbapenemase producing Enterobacteriaceae in the Netherlands in 2013-2014.Multidrug-resistant bacteria in unaccompanied refugee minors arriving in Frankfurt am Main, Germany, October to November 2015.Infection control interventions affected by resource shortages: impact on the incidence of bacteremias caused by carbapenem-resistant pathogens.Multicentre evaluation of the BYG Carba v2.0 test, a simplified electrochemical assay for the rapid laboratory detection of carbapenemase-producing Enterobacteriaceae.Evolving beta-lactamase epidemiology in Enterobacteriaceae from Italian nationwide surveillance, October 2013: KPC-carbapenemase spreading among outpatients.Evaluation of the Carba NP test for carbapenemase detection in Enterobacteriaceae, Pseudomonas spp. and Acinetobacter spp., and its practical use in the routine work of a national reference laboratory for susceptibility testing.Double carbapenem as a rescue strategy for the treatment of severe carbapenemase-producing Klebsiella pneumoniae infections: a two-center, matched case-control study.Efficacy of β-Lactam/β-Lactamase Inhibitor Combinations for the Treatment of Bloodstream Infection Due to Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae in Hematological Patients with Neutropenia.NDM-5 and OXA-181 Beta-Lactamases, a Significant Threat Continues To Spread in the Americas.Carbapenem-resistant Enterobacteriaceae: What we know and what we need to know.The Carbapenemase-Producing Klebsiella pneumoniae Population Is Distinct and More Clonal than the Carbapenem-Susceptible Population.Comparative Evaluation of Four Phenotypic Tests for Detection of Carbapenemase-Producing Gram-Negative Bacteria.Increasing incidence of carbapenemase-producing Escherichia coli and Klebsiella pneumoniae in Belgian hospitals.The global epidemiology of carbapenemase-producing Enterobacteriaceae.Molecular epidemiology of KPC-producing Klebsiella pneumoniae from invasive infections in Italy: increasing diversity with predominance of the ST512 clade II sublineage.Clinical laboratory detection of carbapenem-resistant and carbapenemase-producing Enterobacteriaceae.
P2860
Q26738606-83D66082-ECD6-4241-B311-DBE957F98E98Q26740378-16CAB38D-EE9F-4141-BE86-AE8A09C786EDQ28077354-3BC9C883-DBB2-4695-A251-A08964479529Q30238578-D666E892-36E9-46B2-94C5-7C3682D82EE6Q33813978-56F44133-E648-457E-8C50-0287204019E2Q33813988-D54F7CAF-5D9A-4453-B987-00F052A48CE5Q33816207-A324AE50-72FB-4B7E-928B-4CEB542ECC11Q33909863-CDDC760F-693D-4594-8F65-4CFC0D5FB0EBQ36684198-E3E41F57-06B0-4A5C-BB86-7FF4BFC923A0Q36913345-D55B0F32-AD8E-4E9C-9A9E-BA7BC3FDEDC0Q37040464-49AB88F1-77B9-4012-B86E-FE29DA0BBD91Q37043176-8F5FF44C-DAC0-4792-959E-5D190E35A2FCQ37364751-3B57E111-6B17-4F56-A5B7-437746BCE067Q37479495-DBBBFEFF-00FD-4D35-AEBE-A39055E0D74EQ37521007-B65836F6-53AD-43A9-9AC7-F6179D56FAEFQ37542344-42CA7CF6-A48D-46F9-A9C4-22CC93BC4788Q37612207-CD5E796A-6154-4F5E-B739-B59BD9B3CC78Q37612963-3E309E8E-BCAF-4856-B697-22BCE66B2D08Q37652093-BA47E9A8-B5DC-47F3-BDA0-60B834DE4252Q38776987-5B0F2279-4CAF-400C-AFAD-A9CBBB390286Q38975469-45DA74EB-C035-434B-81DD-AF17576E9EEFQ39028267-75BA60AC-29C4-419E-84D4-252F7F6E8F92Q39484619-6DE99FDF-4D49-41FB-BC5E-C4FDB6297272Q39642029-20B906FE-1757-4E77-8725-4147EF7EFF69Q39812263-7265C642-9E5E-4900-A1F7-94783BF4B62BQ40029789-CF0F2B7C-C47B-42AB-901D-8447595ACA4AQ40063160-F37299BA-88C1-45AA-B8A6-095166075CF9Q40073893-01B936BE-5E0B-44A9-AED7-1F3F22941ABAQ40087078-4A993D8C-B3CB-4B9C-8C1E-439513E32A27Q40108274-90BBB6A8-1335-4178-95A0-9968B9EC24E8Q40146757-8307D923-067A-47B0-B10F-7B17DB3A59BCQ40184233-E7CD955D-E220-47FB-889B-C93C5B838F2DQ40230679-C3061202-7607-4085-A720-31B038EE7E77Q40254332-AF5DA229-EB49-472A-9621-B86082FBEACCQ40352796-AFFE487B-1DBD-4465-9FF7-93EB0A4CBE1AQ40419628-023E387B-6210-40C9-8A12-824C3EB4D9BBQ40536791-DFE1D500-60BF-46DC-8F26-84060C22FC3BQ40552344-4AB61F0C-4736-4D17-8CC4-D6633F0FC4E7Q40554648-D89F1846-C6ED-48E0-8707-88381261446CQ40635231-6A01E236-A4E9-46EC-B73D-AEB0A16577DD
P2860
Carbapenemase-producing Enterobacteriaceae in Europe: assessment by national experts from 38 countries, May 2015.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Carbapenemase-producing Entero ...... s from 38 countries, May 2015.
@en
type
label
Carbapenemase-producing Entero ...... s from 38 countries, May 2015.
@en
prefLabel
Carbapenemase-producing Entero ...... s from 38 countries, May 2015.
@en
P2093
P2860
P1433
P1476
Carbapenemase-producing Entero ...... s from 38 countries, May 2015.
@en
P2093
Barbara Albiger
Corinna Glasner
Dominique L Monnet
European Survey of Carbapenemase-Producing Enterobacteriaceae (EuSCAPE) working group
Hajo Grundmann
Marc J Struelens
P2860
P356
10.2807/1560-7917.ES.2015.20.45.30062
P577
2015-11-01T00:00:00Z